Related Experiment Video

Updated: May 16, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Updates in thrombosis in pediatrics: where are we after 20 years?

Anthony K C Chan1, Paul Monagle

  • 1McMaster University, Department of Pediatrics, Division of Hematology/Oncology, Rm 3N27, 1280 Main St West, Hamilton, ON, L8S 4K1 Canada. akchan@mcmaster.ca

Hematology. American Society of Hematology. Education Program
|December 13, 2012
PubMed

Insights

Pediatric venous thromboembolism (VTE) is rising due to medical advances and better awareness. This review covers recent progress in pediatric thrombosis, including epidemiology, anticoagulants, and VTE outcomes.

Area of Science:

  • Pediatric Hematology
  • Thrombosis Research
  • Medical Technology Impact

Background:

  • Increasing incidence of venous thromboembolism (VTE) in children.
  • Contributing factors include medical technology, improved diagnostics, and enhanced survival for critically ill children.
  • Limited clinical trial data exists for pediatric VTE management.

Purpose of the Study:

  • To review advancements in pediatric thrombosis over the past two decades.
  • To summarize epidemiological shifts in pediatric VTE.
  • To discuss progress in anticoagulant therapies and VTE outcomes in children.

Main Methods:

  • Literature review of recent studies on pediatric thrombosis.
  • Analysis of epidemiological trends in pediatric VTE.
  • Synthesis of data on anticoagulant agents and clinical outcomes.

Main Results:

  • Significant progress has been made in understanding and managing pediatric VTE.
  • Advances in anticoagulant medications offer improved treatment options.
  • Improved survival rates for children with complex medical conditions contribute to VTE incidence.

Conclusions:

  • The field of pediatric thrombosis has seen substantial advancements.
  • Continued research is needed to further refine VTE management strategies in children.
  • Awareness and technological progress are key drivers of observed changes in pediatric VTE.

More Related Videos

A Comprehensive Approach to Analyze the Cell Components of Cerebral Blood Clots06:12

A Comprehensive Approach to Analyze the Cell Components of Cerebral Blood Clots

Published on: July 21, 2023

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...